Rigel Pharmaceuticals. (RIGL) NASDAQ

$1.10 0.02 (1.39%)

Market Cap: $189.44M

As of 04/22/24 11:36 AM EDT. Market open.

(RIGL)

Rigel Pharmaceuticals. (RIGL)
NASDAQ

$1.10
0.02 (1.39%)

Market Cap: $189.44M

As of 04/22/24 11:36 AM EDT. Market open.

Add to Portfolio

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Raul Rodriguez
Full Time Employees
280
CEO Compensation (Base)
$636,540
CEO Compensation (Total)
$3.98M
URL
Address
1180 Veterans Blvd, California, South San Francisco, 94080-1985.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Raul Rodriguez
Full Time Employees
280
CEO Compensation (Base)
$636,540
CEO Compensation (Total)
$3.98M
Address
1180 Veterans Blvd, California, South San Francisco, 94080-1985.
PRICE CHART FOR RIGEL PHARMACEUTICALS
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.06
Previous Close
$1.08
Days Range
$1.01 - $1.08
52 week range
$0.71 - $1.96
Volume
386,370
Avg. Volume (30 days)
1,573,871
Market Cap
$189.44M
Dividend Yield
-
P/E
(7.55)
Shares Outstanding
175,404,663
Open
$1.06
Previous Close
$1.08
Days Range
$1.01 - $1.08
52 week range
$0.71 - $1.96
Volume
386,370
Avg. Volume (30 days)
1,573,871
Market Cap
$189.44M
Dividend Yield
-
P/E
(7.55)
Shares Outstanding
175,404,663
FINANCIAL STATEMENTS FOR RIGEL PHARMACEUTICALS
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR RIGEL PHARMACEUTICALS
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Santos David AEVP, Chief Commercial OfficerFeb 02, 2024 Sale$1.135,6016,329358,011Feb 06, 2024, 08:18 PM
Santos David AEVP, Chief Commercial OfficerFeb 05, 2024 Sale$1.148,91810,167349,093Feb 06, 2024, 08:18 PM
Schorno Dean LEVP & Chief Financial OfficerFeb 05, 2024 Sale$1.147,0278,011402,891Feb 06, 2024, 08:18 PM
Schorno Dean LEVP & Chief Financial OfficerFeb 02, 2024 Sale$1.135,6016,327409,918Feb 06, 2024, 08:18 PM
RODRIGUEZ RAUL RCEO, PresidentFeb 05, 2024 Sale$1.1430,54534,8212,036,629Feb 06, 2024, 08:18 PM
RODRIGUEZ RAUL RCEO, PresidentFeb 02, 2024 Sale$1.1322,34925,2612,067,174Feb 06, 2024, 08:18 PM
RODRIGUEZ RAUL RCEO, PresidentFeb 06, 2023 Sale$1.7520,34035,5951,680,713Feb 07, 2023, 04:30 PM
Santos David AEVP, Chief Commercial OfficerFeb 02, 2023 Sale$1.665,3888,945144,612Feb 06, 2023, 05:41 PM
Schorno Dean LEVP & Chief Financial OfficerFeb 02, 2023 Sale$1.665,3898,946196,519Feb 06, 2023, 05:40 PM
Dummer WolfgangEVP & CMOFeb 02, 2023 Sale$1.665,3898,94672,459Feb 06, 2023, 05:40 PM
RODRIGUEZ RAUL RCEO, PresidentJun 09, 2022 Buy$0.691,000,000688,4001,391,776Jun 13, 2022, 04:36 PM
Schorno Dean LEVP &Chief Financial OfficerMay 22, 2019 Buy$2.1350,000106,54450,000May 23, 2019, 08:21 PM
Cabatuan NelsonPrincipal Accounting OfficerOct 12, 2018 Sale$3.1210,00031,20058Oct 16, 2018, 06:46 PM
Duliege Anne-MarieEVP & Chief Medical OfficerSep 17, 2018 Option Exercise$2.43153,000372,495115,500Sep 19, 2018, 06:26 PM
Duliege Anne-MarieEVP & Chief Medical OfficerSep 17, 2018 Sale$3.50153,000535,5000Sep 19, 2018, 06:26 PM
Mayer Eldon C. IIIEVP & Chief Commercial OfficerSep 11, 2018 Buy$3.2350,000161,340215,000Sep 12, 2018, 12:00 AM
Mayer Eldon C. IIIEVP & Chief Commercial OfficerSep 10, 2018 Buy$3.2850,000164,210165,000Sep 12, 2018, 12:00 AM
Duliege Anne-MarieEVP & Chief Medical OfficerSep 04, 2018 Option Exercise$2.5416,50041,91016,500Sep 06, 2018, 07:02 PM
Duliege Anne-MarieEVP & Chief Medical OfficerSep 04, 2018 Sale$3.5116,50057,8610Sep 06, 2018, 07:02 PM
Mayer Eldon C. IIIEVP & Chief Commercial OfficerAug 23, 2018 Buy$2.82100,000282,320115,000Aug 27, 2018, 07:49 PM
RODRIGUEZ RAUL RCEO, PresidentAug 17, 2018 Buy$2.63114,000300,002173,519Aug 21, 2018, 07:12 PM
Duliege Anne-MarieEVP & Chief Medical OfficerJul 02, 2018 Sale$2.795,00013,9320Jul 05, 2018, 06:59 PM
Duliege Anne-MarieEVP & Chief Medical OfficerApr 20, 2018 Sale$4.115,00020,5500Apr 24, 2018, 09:06 PM
Maynard Ryan DEVP & CFONov 03, 2017 Option Exercise$2.14100,000214,000100,000Nov 07, 2017, 09:07 PM
Maynard Ryan DEVP & CFONov 03, 2017 Sale$3.90100,000390,0000Nov 07, 2017, 09:07 PM
Duliege Anne-MarieChief Medical OfficerJul 05, 2017 Sale$2.695,00013,4270Jul 07, 2017, 05:39 PM
Duliege Anne-MarieChief Medical OfficerJan 03, 2017 Sale$2.415,00012,0270Jan 13, 2017, 06:02 PM
PAYAN DONALD GEVP, Pres. Discovery&ResearchAug 30, 2016 Sale$4.005,30321,21453,031Sep 01, 2016, 06:18 PM
PAYAN DONALD GEVP, Pres. Discovery&ResearchJun 10, 2015 Option Exercise$2.1441,66689,165100,000Jun 12, 2015, 07:22 PM
PAYAN DONALD GEVP, Pres. Discovery&ResearchJun 10, 2015 Sale$3.6841,666153,21458,334Jun 12, 2015, 07:22 PM
PAYAN DONALD GEVP, Pres. Discovery&ResearchApr 01, 2015 Sale$3.7510,00037,51858,334Apr 03, 2015, 08:35 PM
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.Dec 18, 2014 Sale$2.221,0002,220575Dec 22, 2014, 06:26 PM
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.Dec 18, 2014 Sale$2.221,0002,220575Dec 19, 2014, 06:56 PM
PAYAN DONALD GEVP, Pres. Discovery&ResearchSep 03, 2014 Sale$2.5620,00051,20068,334Sep 05, 2014, 06:07 PM
PAYAN DONALD GEVP, Pres. Discovery&ResearchFeb 24, 2014 Sale$3.7120,00074,23888,334Feb 26, 2014, 07:21 PM
BVF PARTNERS L P/IL10% OwnerNov 19, 2013 Sale$2.64484,6221,280,2741,123,848Nov 20, 2013, 02:13 PM
BVF PARTNERS L P/IL10% OwnerJun 07, 2013 Buy$3.4732,700113,3941,455,414Jun 11, 2013, 05:55 PM
Maynard Ryan DEVP & CFOSep 12, 2012 Option Exercise$6.4923,302151,23023,302Sep 14, 2012, 07:57 PM
Maynard Ryan DEVP & CFOSep 12, 2012 Sale$10.6723,302248,5600Sep 14, 2012, 07:57 PM
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.Sep 13, 2012 Sale$10.434,15143,2841,103Sep 14, 2012, 06:45 PM
Maynard Ryan DEVP & CFOSep 07, 2012 Option Exercise$6.4923,302151,23023,302Sep 14, 2012, 06:19 PM
Maynard Ryan DEVP & CFOSep 07, 2012 Sale$10.6723,302248,5600Sep 14, 2012, 06:19 PM
Maynard Ryan DEVP & CFOSep 10, 2012 Option Exercise$6.4917,586114,13317,586Sep 11, 2012, 06:07 PM
Maynard Ryan DEVP & CFOSep 07, 2012 Option Exercise$6.4934,112221,38734,112Sep 11, 2012, 06:07 PM
Maynard Ryan DEVP & CFOSep 10, 2012 Sale$10.5217,586184,9270Sep 11, 2012, 06:07 PM
Maynard Ryan DEVP & CFOSep 07, 2012 Sale$10.5534,112359,9600Sep 11, 2012, 06:07 PM
Maynard Ryan DEVP & CFOAug 07, 2012 Option Exercise$6.491,70011,0331,700Aug 09, 2012, 05:39 PM
Maynard Ryan DEVP & CFOAug 07, 2012 Sale$10.611,70018,0411,000Aug 09, 2012, 05:39 PM
PAYAN DONALD GEVP, Pres. Discovery&ResearchJun 19, 2012 Sale$8.7010,00087,008118,234Jun 20, 2012, 05:45 PM
Flynn James E10% OwnerMay 26, 2011 Buy$8.00301,4242,411,3923,204,167Jun 07, 2011, 05:27 PM
Flynn James E10% OwnerMay 26, 2011 Buy$8.00229,2521,834,0162,279,997Jun 07, 2011, 05:27 PM
Flynn James E10% OwnerMay 26, 2011 Buy$8.0072,800582,400762,700Jun 07, 2011, 05:27 PM
Flynn James E10% OwnerMay 26, 2011 Buy$8.0046,524372,192470,425Jun 07, 2011, 05:27 PM
Flynn James E10% OwnerNov 03, 2010 Sale$7.555163,896423,901Nov 05, 2010, 05:39 PM
Flynn James E10% OwnerNov 03, 2010 Sale$7.553,69027,8602,902,743Nov 05, 2010, 05:39 PM
Flynn James E10% OwnerNov 03, 2010 Sale$7.552,60519,6682,050,745Nov 05, 2010, 05:39 PM
Flynn James E10% OwnerNov 03, 2010 Sale$7.559006,795689,900Nov 05, 2010, 05:39 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Santos David AEVP, Chief Commercial Officer02/02/20246,329
Santos David AEVP, Chief Commercial Officer02/05/202410,167
Schorno Dean LEVP & Chief Financial Officer02/05/20248,011
Schorno Dean LEVP & Chief Financial Officer02/02/20246,327
RODRIGUEZ RAUL RCEO, President02/05/202434,821
RODRIGUEZ RAUL RCEO, President02/02/202425,261
RODRIGUEZ RAUL RCEO, President02/06/202335,595
Santos David AEVP, Chief Commercial Officer02/02/20238,945
Schorno Dean LEVP & Chief Financial Officer02/02/20238,946
Dummer WolfgangEVP & CMO02/02/20238,946
RODRIGUEZ RAUL RCEO, President06/09/2022688,400
Schorno Dean LEVP &Chief Financial Officer05/22/2019106,544
Cabatuan NelsonPrincipal Accounting Officer10/12/201831,200
Duliege Anne-MarieEVP & Chief Medical Officer09/17/2018372,495
Duliege Anne-MarieEVP & Chief Medical Officer09/17/2018535,500
Mayer Eldon C. IIIEVP & Chief Commercial Officer09/11/2018161,340
Mayer Eldon C. IIIEVP & Chief Commercial Officer09/10/2018164,210
Duliege Anne-MarieEVP & Chief Medical Officer09/04/201841,910
Duliege Anne-MarieEVP & Chief Medical Officer09/04/201857,861
Mayer Eldon C. IIIEVP & Chief Commercial Officer08/23/2018282,320
RODRIGUEZ RAUL RCEO, President08/17/2018300,002
Duliege Anne-MarieEVP & Chief Medical Officer07/02/201813,932
Duliege Anne-MarieEVP & Chief Medical Officer04/20/201820,550
Maynard Ryan DEVP & CFO11/03/2017214,000
Maynard Ryan DEVP & CFO11/03/2017390,000
Duliege Anne-MarieChief Medical Officer07/05/201713,427
Duliege Anne-MarieChief Medical Officer01/03/201712,027
PAYAN DONALD GEVP, Pres. Discovery&Research08/30/201621,214
PAYAN DONALD GEVP, Pres. Discovery&Research06/10/201589,165
PAYAN DONALD GEVP, Pres. Discovery&Research06/10/2015153,214
PAYAN DONALD GEVP, Pres. Discovery&Research04/01/201537,518
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.12/18/20142,220
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.12/18/20142,220
PAYAN DONALD GEVP, Pres. Discovery&Research09/03/201451,200
PAYAN DONALD GEVP, Pres. Discovery&Research02/24/201474,238
BVF PARTNERS L P/IL10% Owner11/19/20131,280,274
BVF PARTNERS L P/IL10% Owner06/07/2013113,394
Maynard Ryan DEVP & CFO09/12/2012151,230
Maynard Ryan DEVP & CFO09/12/2012248,560
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.09/13/201243,284
Maynard Ryan DEVP & CFO09/07/2012151,230
Maynard Ryan DEVP & CFO09/07/2012248,560
Maynard Ryan DEVP & CFO09/10/2012114,133
Maynard Ryan DEVP & CFO09/07/2012221,387
Maynard Ryan DEVP & CFO09/10/2012184,927
Maynard Ryan DEVP & CFO09/07/2012359,960
Maynard Ryan DEVP & CFO08/07/201211,033
Maynard Ryan DEVP & CFO08/07/201218,041
PAYAN DONALD GEVP, Pres. Discovery&Research06/19/201287,008
Flynn James E10% Owner05/26/20112,411,392
Flynn James E10% Owner05/26/20111,834,016
Flynn James E10% Owner05/26/2011582,400
Flynn James E10% Owner05/26/2011372,192
Flynn James E10% Owner11/03/20103,896
Flynn James E10% Owner11/03/201027,860
Flynn James E10% Owner11/03/201019,668
Flynn James E10% Owner11/03/20106,795
Load More Insider Transactions
FUNDS WITH A POSITION IN RIGEL PHARMACEUTICALS
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.15,198,0770.00056%5.44%Other
GEODE CAPITAL MANAGEMENT, LLC3,692,6990.00056%4.1%Other
RENAISSANCE TECHNOLOGIES LLC1,318,2260.00296%16.47%Other
UBS OCONNOR LLC899,3350.09%-21.92%Value
CHANGE IN SHARES OUTSTANDING FOR RIGEL PHARMACEUTICALS
STOCK BUYBACKS FOR RIGEL PHARMACEUTICALS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.01%
1Q
12/31/2023
06/30/2023
0.36%
2Q
12/31/2023
03/31/2023
0.47%
3Q
12/31/2023
12/31/2022
0.88%
4Q
12/31/2023
09/30/2022
0.89%
5Q
12/31/2023
06/30/2022
1.30%
6Q
12/31/2023
03/31/2022
1.52%
7Q
12/31/2023
12/31/2021
14.26%
8Q
12/31/2023
09/30/2021
2.04%
9Q
12/31/2023
06/30/2021
2.46%
10Q
12/31/2023
03/31/2021
-0.96%
11Q
12/31/2023
12/31/2020
3.16%
12Q
12/31/2023
09/30/2020
3.22%
13Q
12/31/2023
06/30/2020
3.44%
14Q
12/31/2023
03/31/2020
3.45%
15Q
12/31/2023
12/31/2019
4.03%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.01%
1Q
06/30/2023
0.36%
2Q
03/31/2023
0.47%
3Q
12/31/2022
0.88%
4Q
09/30/2022
0.89%
5Q
06/30/2022
1.30%
6Q
03/31/2022
1.52%
7Q
12/31/2021
14.26%
8Q
09/30/2021
2.04%
9Q
06/30/2021
2.46%
10Q
03/31/2021
-0.96%
11Q
12/31/2020
3.16%
12Q
09/30/2020
3.22%
13Q
06/30/2020
3.44%
14Q
03/31/2020
3.45%
15Q
12/31/2019
4.03%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR RIGEL PHARMACEUTICALS
LOADING...